Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation

被引:25
|
作者
Laryea, Marie A. [2 ]
Watt, Kymberly D. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Dalhousie Univ, Multiorgan Transplant Program, Halifax, NS, Canada
关键词
B IMMUNE GLOBULIN; HBV-RELATED CIRRHOSIS; TERM-FOLLOW-UP; VIRUS RECURRENCE; ADEFOVIR DIPIVOXIL; SURFACE-ANTIGEN; POSITIVE GRAFTS; LOW-RISK; LAMIVUDINE; PROPHYLAXIS;
D O I
10.1002/lt.23408
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The reinfection of the hepatic allograft with hepatitis B virus and hepatitis C virus can have important sequelae that result in poor long-term patient and graft survival. Although a response to treatment with antiviral medications can improve these outcomes, not all patients tolerate these medications or experience viral eradication. Avoiding reinfection of the graft is the most effective means of improving the long-term outcomes for these patient populations. This review is focused on the prevention of viral hepatitis reinfection after liver transplantation. Liver Transpl, 2012. (C) 2012 AASLD.
引用
收藏
页码:514 / 523
页数:10
相关论文
共 50 条
  • [21] Immunoprophylaxis of viral hepatitis
    Jilg, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1997, 35 : 585 - 590
  • [22] IMMUNOPROPHYLAXIS FOR HEPATITIS-B VIRUS REINFECTION AFTER LIVER-TRANSPLANTATION
    JENG, LBB
    LEE, WC
    YEH, DS
    WANG, CC
    WANG, KL
    CHEN, SC
    CHEN, MF
    CHIEN, RN
    CHIU, CT
    LIN, DY
    LIAW, YF
    TAN, PPC
    CHANG, CH
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (04) : 2243 - 2244
  • [23] Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment
    Mazzaferro, V
    Tagger, A
    Schiavo, M
    Regalia, E
    Pulvirenti, A
    Ribero, ML
    Coppa, J
    Romito, R
    Burgoa, L
    Zucchini, N
    Urbanek, T
    Bonino, F
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1355 - 1357
  • [24] Prevention of hepatitis B after liver transplantation
    Suh, KS
    Yi, NJ
    Chang, SH
    Choi, SH
    Lee, KU
    LIVER TRANSPLANTATION, 2003, 9 (06) : C9 - C9
  • [25] Limited lamivudine and long-term hepatitis B immunoglobulin immunoprophylaxis for prevention of hepatitis B recurrence after liver transplantation.
    Starkel, P
    Cicarelli, O
    Lerut, J
    Goubau, P
    Rahier, J
    Horsmans, Y
    TRANSPLANTATION, 2002, 74 (03) : 408 - 410
  • [26] Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
    Guillouche, P.
    Feray, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 163 - 174
  • [27] Recurrent hepatitis C virus infection after liver transplantation: Immunohistochemical assessment of the viral antigen
    Vargas, V
    Krawczynski, K
    Castells, L
    Martinez, N
    Esteban, J
    Allende, H
    Esteban, R
    Guardia, J
    LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (04): : 320 - 327
  • [28] Prevention of recurrent hepatitis B post-liver transplantation
    Lok, ASF
    LIVER TRANSPLANTATION, 2002, 8 (10) : S67 - S73
  • [29] Pathogenesis of recurrent hepatitis C after liver transplantation
    Roberto J. Firpi
    David R. Nelson
    Current Hepatitis Reports, 2005, 4 (4) : 138 - 144
  • [30] Treatment of recurrent hepatitis C after liver transplantation
    倪鎏达
    陈成伟
    中华肝脏病杂志, 2005, (03) : 92 - 94